Close

In Specialty Pharma, Short Interst in Abbott (ABT), Endo (ENDP) and Valeant (VRX) Surge

May 24, 2016 5:12 PM EDT
Get Alerts ABT Hot Sheet
Price: $113.21 -0.24%

Rating Summary:
    18 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE

Providing commentary on the latest short interest data for the Specialty Pharmaceuticals space, Guggenheim's Louise Chen noted that for the period ended 05/13/16, the largest increase in short interest is Abbott (NYSE: ABT) at +307.3%. Notably, Abbott announced a deal to acquire St. Jude Medical, Inc (NYSE: STJ) during the period.

Meanwhile, the largest decrease in short interest was Pfizer (NYSE: PFE) at -22.3%.

Among heavily-shorted Specialty Pharmaceuticals stocks:

  • Endo Pharmaceuticals (NASDAQ: ENDP) saw its short interest rise 51.3% to 9,137,196 shares.
  • Valeant Pharmaceuticals (NYSE; VRX) saw its short interest rise 44.2% to 24,239,629 shares
  • Mallinckrodt plc (NYSE: MNK) saw its short interest rise 11% to 12,799,313 shares.
  • Horizon Pharma (NASDAQ: HZNP) saw its short interest rise 1.7% to 15,604,946 shares.
  • Shire (NASDAQ: SHPG) saw its short interest fall 0.4% to 19,663,451 shares.
  • Zoetis (NYSE: ZTS) saw its short interest fall 10% to 7,099,376 shares.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Short Sales, Trader Talk

Related Entities

Definitive Agreement, Louise Chen, Guggenheim